Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants

Journal of Pediatrics

Volumn 177, Issue , 2016, Pages 66-71.e1

  Sung, Se In ^a   Chang, Yun Sil ^a   Chun, Ji Young ^a   Yoon, Shin Ae ^a   Yoo, Hye Soo ^a   Ahn, So Yoon ^a   Park, Won Soon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

ductal ligation; ibuprofen; indomethacin; patent ductus arteriosus; preterm infant

Indexed keywords

INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADVERSE OUTCOME; ARTICLE; ASSISTED VENTILATION; BRAIN HEMORRHAGE; CALORIC INTAKE; CONTROLLED STUDY; FEMALE; FLUID INTAKE; GESTATIONAL AGE; HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS; HUMAN; INCIDENCE; INFANT; KIDNEY FUNCTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; NEONATAL INTENSIVE CARE UNIT; OBSERVATIONAL STUDY; PATENT DUCTUS ARTERIOSUS; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; ADVERSE EFFECTS; DUCTUS ARTERIOSUS, PATENT; NEWBORN; PROCEDURES; RECONSTRUCTIVE SURGERY; VERY LOW BIRTH WEIGHT;

CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; PROPENSITY SCORE; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES;

EID: 84978946446     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.06.046     Document Type: Article

References (40)

1. 1 Noori, S., McCoy, M., Friedlich, P., Bright, B., Gottipati, V., Seri, I., et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123 (2009), e138–44.
2. 2 Benitz, W.E., Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?. J Perinatol 30 (2010), 241–252.
3. 3 Bose, C.L., Laughon, M.M., Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 92 (2007), F498–502.
4. 4 Kaempf, J.W., Wu, Y.X., Kaempf, A.J., Kaempf, A.M., Wang, L., Grunkemeier, G., What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?. J Perinatol 32 (2012), 344–348.
5. 5 Clyman, R.I., The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Semin Perinatol 37 (2013), 102–107.
6. 6 Mirea, L., Sankaran, K., Seshia, M., Ohlsson, A., Allen, A.C., Aziz, K., et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr 161 (2012), 689–694 e1.
7. 7 Teixeira, L.S., Shivananda, S.P., Stephens, D., Van Arsdell, G., McNamara, P.J., Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. J Perinatol 28 (2008), 803–810.
8. 8 Chang, L.Y., McCurnin, D., Yoder, B., Shaul, P.W., Clyman, R.I., Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res 63 (2008), 299–302.
9. 9 Sehgal, A., Paul, E., Menahem, S., Functional echocardiography in staging for ductal disease severity: role in predicting outcomes. Eur J Pediatr 172 (2013), 179–184.
10. 10 Hamrick, S.E., Hansmann, G., Patent ductus arteriosus of the preterm infant. Pediatrics 125 (2010), 1020–1030.
11. 11 Herrman, K., Bose, C., Lewis, K., Laughon, M., Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 94 (2009), F48–50.
12. 12 Pietz, J., Achanti, B., Lilien, L., Stepka, E.C., Mehta, S.K., Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience. Pediatrics 119 (2007), e164–70.
13. 13 Vanhaesebrouck, S., Zonnenberg, I., Vandervoort, P., Bruneel, E., Van Hoestenberghe, M.-R., Theyskens, C., Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed 92 (2007), F244–7.
14. 14 Nemerofsky, S.L., Parravicini, E., Bateman, D., Kleinman, C., Polin, R.A., Lorenz, J.M., The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol 25 (2008), 661–666.
15. 15 Ehrenkranz, R.A., Walsh, M.C., Vohr, B.R., Jobe, A.H., Wright, L.L., Fanaroff, A.A., et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116 (2005), 1353–1360.
16. 16 Papile, L.A., Burstein, J., Burstein, R., Koffler, H., Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 92 (1978), 529–534.
17. 17 Bell, M.J., Ternberg, J.L., Feigin, R.D., Keating, J.P., Marshall, R., Barton, L., et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187 (1978), 1–7.
18. 18 An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 102 (1984), 1130–1134.
19. 19 Jhaveri, N., Moon-Grady, A., Clyman, R.I., Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr 157 (2010), 381–387 7.e1.
20. 20 Kabra, N.S., Schmidt, B., Roberts, R.S., Doyle, L.W., Papile, L., Fanaroff, A., et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 150 (2007), 229–234 34 e1.
21. 21 Madan, J.C., Kendrick, D., Hagadorn, J.I., Frantz, I.D. 3rd, National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 123 (2009), 674–681.
22. 22 McNamara, P.J., Sehgal, A., Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 92 (2007), F424–7.
23. 23 Chock, V.Y., Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus. Pediatr Res 75 (2014), 570–575.
24. 24 Schena, F., Francescato, G., Cappelleri, A., Picciolli, I., Mayer, A., Mosca, F., et al. Association between hemodynamically significant patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr 166 (2015), 1488–1492.
25. 25 Dani, C., Bertini, G., Corsini, I., Elia, S., Vangi, V., Pratesi, S., et al. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance. Acta Paediatr 97 (2008), 1176–1180.
26. 26 Rolland, A., Shankar-Aguilera, S., Diomandé, D., Zupan-Simunek, V., Boileau, P., Natural evolution of patent ductus arteriosus in the extremely preterm infant. Arch Dis Child Fetal Neonatal Ed 100 (2014), F55–8.
27. 27 Stephens, B.E., Gargus, R.A., Walden, R.V., Mance, M., Nye, J., McKinley, L., et al. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants. J Perinatol 28 (2008), 123–128.
28. 28 Oh, W., Poindexter, B.B., Perritt, R., Lemons, J.A., Bauer, C.R., Ehrenkranz, R.A., et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 147 (2005), 786–790.
29. 29 Kim, S.M., Lee, E.Y., Chen, J., Ringer, S.A., Improved care and growth outcomes by using hybrid humidified incubators in very preterm infants. Pediatrics 125 (2010), e137–45.
30. 30 Sung, S.I., Ahn, S.Y., Seo, H.J., Yoo, H.S., Han, Y.M., Lee, M.S., et al. Insensible water loss during the first week of life of extremely low birth weight infants less than 25 gestational weeks under high humidification. Neonatal Medicine 20 (2013), 51–57.
31. 31 Chess, P.R., D'Angio, C.T., Pryhuber, G.S., Maniscalco, W.M., Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol 30 (2006), 171–178.
32. 32 Dudell, G.G., Gersony, W.M., Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 104 (1984), 915–920.
33. 33 Jacob, J., Gluck, L., DiSessa, T., Edwards, D., Kulovich, M., Kurlinski, J., et al. The contribution of PDA in the neonate with severe RDS. J Pediatr 96 (1980), 79–87.
34. 34 Martin, C.G., Snider, A.R., Katz, S.M., Peabody, J.L., Brady, J.P., Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosus. J Pediatr 101 (1982), 587–593.
35. 35 McCurnin, D., Seidner, S., Chang, L.Y., Waleh, N., Ikegami, M., Petershack, J., et al. Ibuprofen- induced patent ductus arteriosus closure: physiologic, histologic, and biochemical effects on the premature lung. Pediatrics 121 (2008), 945–956.
36. 36 McCurnin, D.C., Yoder, B.A., Coalson, J., Grubb, P., Kerecman, J., Kupferschmid, J., et al. Effect of ductus ligation on cardiopulmonary function in premature baboons. Am J Respir Crit Care Med 172 (2005), 1569–1574.
37. 37 Clyman, R.I., Couto, J., Murphy, G.M., Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?. Semin Perinatol 36 (2012), 123–129.
38. 38 Chorne, N., Leonard, C., Piecuch, R., Clyman, R.I., Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 119 (2007), 1165–1174.
39. 39 Clyman, R., Cassady, G., Kirklin, J.K., Collins, M., Philips, J.B. 3rd., The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 154 (2009), 873–876.
40. 40 Keszler, M., Sant'Anna, G., Mechanical ventilation and bronchopulmonary dysplasia. Clin Perinatol 42 (2015), 781–796.